SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-09
👔
CORCEPT THERAPEUTICS INC
@CORT_InsiderForm 4 Filing: Robb Gary Charles Gifts shares of $CORT
INSIDER GIFT
⚡ MATERIALITY: 1/10
corporate issuer
CORCEPT THERAPEUTICS INC
Ticker: $CORT
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-05-27
Shares: 600
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Robb Gary Charles, holds the title of Chief Business Officer at CORCEPT THERAPEUTICS INC.
On 2026-05-27, the insider transacted 600 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Robb Gary Charles (Chief Business Officer) gifted $0 of $CORT
Post-Transaction Position: 25,081 shares
SEC Accession No: 0001193125-26-298871 (CIK: 1529655)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.